Cargando…
Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380287/ https://www.ncbi.nlm.nih.gov/pubmed/35971067 http://dx.doi.org/10.1186/s11658-022-00369-x |
| _version_ | 1784768853726724096 |
|---|---|
| author | Huang, Han-Ming Huang, Xiao-Yu Wu, Shao-Ping Chen, Can-Keng He, Xin-Hua Zhang, Yong-Fa |
| author_facet | Huang, Han-Ming Huang, Xiao-Yu Wu, Shao-Ping Chen, Can-Keng He, Xin-Hua Zhang, Yong-Fa |
| author_sort | Huang, Han-Ming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9380287 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93802872022-08-17 Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway Huang, Han-Ming Huang, Xiao-Yu Wu, Shao-Ping Chen, Can-Keng He, Xin-Hua Zhang, Yong-Fa Cell Mol Biol Lett Retraction Note BioMed Central 2022-08-15 /pmc/articles/PMC9380287/ /pubmed/35971067 http://dx.doi.org/10.1186/s11658-022-00369-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Huang, Han-Ming Huang, Xiao-Yu Wu, Shao-Ping Chen, Can-Keng He, Xin-Hua Zhang, Yong-Fa Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title | Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title_full | Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title_fullStr | Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title_full_unstemmed | Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title_short | Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway |
| title_sort | retraction note to: parecoxib inhibits esophageal squamous cell carcinoma progression via the pdk1–akt pathway |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380287/ https://www.ncbi.nlm.nih.gov/pubmed/35971067 http://dx.doi.org/10.1186/s11658-022-00369-x |
| work_keys_str_mv | AT huanghanming retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway AT huangxiaoyu retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway AT wushaoping retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway AT chencankeng retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway AT hexinhua retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway AT zhangyongfa retractionnotetoparecoxibinhibitsesophagealsquamouscellcarcinomaprogressionviathepdk1aktpathway |